Combined treatment of ulinastatin and tranexamic acid provides beneficial effects by inhibiting inflammatory and fibrinolytic response in patients undergoing heart valve replacement surgery - Chen, T T; Wang, G; Jiang, S L; Li, L B; Gao, C Q (Heart Surg Forum, 2013)